![Wei Wu He](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wei Wu He
Fondateur chez
Emerging Technology Partners LLC
Fortune : 223 171 $ au 31/03/2026
Profil
Wei Wu He was the founder of Chongqing TCR CURE Biopharma Technology Co., Ltd (2016), Beijing TCRcure Biotechnology Co., Ltd. (2016), Intradigm Corp.
(2000) serving as Director, Emerging Technology Partners LLC (2000) serving as General Partner, DoctorsForMe, Inc. (2018) serving as Chief Executive & Financial Officer, OriGene Technologies, Inc. (1995-2019) serving as Chief Executive Officer, and Genetron Holdings Ltd. (2015) serving as Chairman.
Current jobs include Executive Chairman at Human Longevity, Inc. since 2019, Chairman at Beijing Genetron Biotechnology Co. Ltd., Chairman at Beijing Genetron Health Gene Technology Co., Ltd., Director at MithraGen, Inc., and Trustee at J.
Craig Venter Institute, Inc. Former jobs include Chairman & Chief Executive Officer at Cytomyx Holdings Plc, Executive Chairman at CASI Pharmaceuticals, Inc. from 2018 to 2019, Director at Amnis Corp., and President at Human Genome Sciences, Inc. Education includes a doctorate from Baylor College of Medicine (1990), an MBA from The Wharton School of the University of Pennsylvania (1999), and an undergraduate degree from Nanjing University (1985).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/05/2026 | 2 010 550 ( 12,98% ) | 223 171 $ | 31/03/2026 |
Postes actifs de Wei Wu He
| Sociétés | Poste | Début |
|---|---|---|
Emerging Technology Partners LLC
 Emerging Technology Partners LLC Investment ManagersFinance ETP invests in companies located in the United States and China. The firm targets companies operating in the field of biomedical industry. It participates in seed, early and late-stage transactions. The firm acts as a lead investor and makes co-investments. | Fondateur | 01/01/2000 |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Fondateur | 01/01/2000 |
MithraGen, Inc.
 MithraGen, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment and prevention of cancer and infectious diseases | Directeur/Membre du Conseil | 14/08/2009 |
Beijing Genetron Biotechnology Co. Ltd.
 Beijing Genetron Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides molecular diagnosis and therapeutics for cancer patients | Président | - |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Provides genomics and cell therapy-based diagnostic and therapeutic services | Président | 01/07/2019 |
Beijing Genetron Health Gene Technology Co., Ltd.
 Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Engages in technology development | Président | - |
J. Craig Venter Institute, Inc.
 J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit genomics research organization | Directeur/Membre du Conseil | - |
Anciens postes connus de Wei Wu He
| Sociétés | Poste | Fin |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Directeur Général | 21/07/2025 |
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Develops immunotherapy for T cell cancer | Fondateur | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Wei Wu He
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Amnis Corp.
 Amnis Corp. BiotechnologyHealth Technology Provides cell imaging and instrument development, manufacturing and marketing services | Health Technology |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Health Technology |
Cytomyx Holdings Plc
 Cytomyx Holdings Plc Pharmaceuticals: MajorHealth Technology Provides drug discovery products and services | Health Technology |
Emerging Technology Partners LLC
Emerging Technology Partners LLC Investment ManagersFinance ETP invests in companies located in the United States and China. The firm targets companies operating in the field of biomedical industry. It participates in seed, early and late-stage transactions. The firm acts as a lead investor and makes co-investments. | Finance |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MithraGen, Inc.
MithraGen, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment and prevention of cancer and infectious diseases | Health Technology |
OriGene Technologies, Inc.
 OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops genome wide research tools and technology platforms | Commercial Services |
J. Craig Venter Institute, Inc.
J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit genomics research organization | Commercial Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Provides genomics and cell therapy-based diagnostic and therapeutic services | Health Technology |
Beijing Genetron Biotechnology Co. Ltd.
Beijing Genetron Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides molecular diagnosis and therapeutics for cancer patients | Health Technology |
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Engages in technology development | Technology Services |
DoctorsForMe, Inc.
 DoctorsForMe, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Provides molecular profiling and diagnostics services | Health Services |
Chongqing TCR CURE Biopharma Technology Co., Ltd
Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Develops immunotherapy for T cell cancer | Health Technology |
Beijing TCRcure Biotechnology Co., Ltd.
 Beijing TCRcure Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and markets tumor immune cell therapy technology | Commercial Services |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
Choisissez Zonebourse 
